A randomized international trial led by the University of British Columbia found that starting treatment with a minimally invasive approach for advanced atrial fibrillation reduced the need for initial drug-based management. Results were published in the New England Journal of Medicine, with the study challenging the longstanding practice of beginning with medication first. The finding adds clinical weight to procedural-first strategies for complex AF populations.